• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度东部内脏利什曼病和黑热病后皮肤利什曼病菌株之间的遗传异质性。

Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India.

作者信息

Dey Ayan, Singh Sarman

机构信息

Division of Clinical Microbiology, Department of Laboratory Medicine, All India Institute of Medical Sciences, New Delhi 110029, India.

出版信息

Infect Genet Evol. 2007 Mar;7(2):219-22. doi: 10.1016/j.meegid.2006.09.001. Epub 2006 Oct 5.

DOI:10.1016/j.meegid.2006.09.001
PMID:17027344
Abstract

In India and Sudan, some patients of visceral leishmaniasis develop post-Kala-Azar dermal leishmaniasis (PKDL) while majority will not. Similarly, the clinical manifestations and treatment outcome are reported to vary from district to district and state to state in India. Present study is focused on to find out the genetic variations between VL & PKDL causing strains. Nuclear DNA from 24 strains of Leishmania donovani, isolated from patients of visceral leishmaniasis (18) and PKDL (6) was extracted and digested with PstI restriction enzyme followed by southern hybridization using Dig labeled beta-tubulin as probe. The results showed three different banding patterns among 18 VL strains. However, all PKDL isolates showed a genetic homogeneity within themselves but heterogeneity from VL isolates. Interestingly maximum heterogenic groups were found in Bihar but all isolates from West Bengal showed a single genotype origin. This study shows that genetic mutations might be responsible for such variation and development of PKDL in visceral strains of Indian L. donovani.

摘要

在印度和苏丹,一些内脏利什曼病患者会发展为黑热病后皮肤利什曼病(PKDL),而大多数患者不会。同样,据报道,在印度,不同地区和邦的临床表现和治疗结果也有所不同。本研究旨在找出导致内脏利什曼病(VL)和PKDL的菌株之间的基因变异。从内脏利什曼病患者(18例)和PKDL患者(6例)中分离出24株杜氏利什曼原虫的核DNA,用PstI限制性内切酶消化,然后以地高辛标记的β-微管蛋白为探针进行Southern杂交。结果显示,18株VL菌株中有三种不同的条带模式。然而,所有PKDL分离株自身显示出基因同质性,但与VL分离株存在异质性。有趣的是,在比哈尔邦发现了最大的异源群体,但来自西孟加拉邦的所有分离株都显示出单一的基因型起源。这项研究表明,基因突变可能是印度杜氏利什曼原虫内脏菌株中PKDL这种变异和发展的原因。

相似文献

1
Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India.印度东部内脏利什曼病和黑热病后皮肤利什曼病菌株之间的遗传异质性。
Infect Genet Evol. 2007 Mar;7(2):219-22. doi: 10.1016/j.meegid.2006.09.001. Epub 2006 Oct 5.
2
Multilocus microsatellite typing (MLMT) reveals genetic homogeneity of Leishmania donovani strains in the Indian subcontinent.多位点微卫星分型(MLMT)揭示了印度次大陆杜氏利什曼原虫菌株的遗传同质性。
Infect Genet Evol. 2009 Jan;9(1):24-31. doi: 10.1016/j.meegid.2008.09.005. Epub 2008 Oct 8.
3
Genetic fingerprinting and identification of differentially expressed genes in isolates of Leishmania donovani from Indian patients of post-kala-azar dermal leishmaniasis.来自印度黑热病后皮肤利什曼病患者的杜氏利什曼原虫分离株的基因指纹分析及差异表达基因的鉴定
Parasitology. 2008 Jan;135(Pt 1):23-32. doi: 10.1017/S0031182007003484. Epub 2007 Aug 28.
4
Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.评估来自印度的对锑敏感和耐药的利什曼原虫临床分离株中的水甘油通道蛋白基因状态和表达谱。
J Antimicrob Chemother. 2010 Mar;65(3):496-507. doi: 10.1093/jac/dkp468. Epub 2010 Jan 12.
5
Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.印度比哈尔邦内脏利什曼病流行地区的黑热病后皮肤利什曼病。
Trop Med Int Health. 2012 Nov;17(11):1345-8. doi: 10.1111/j.1365-3156.2012.03067.x. Epub 2012 Aug 12.
6
Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.内脏利什曼病,即黑热病(KA):通过黑热病后皮肤利什曼病的人传人传播导致对锑难治性的高发生率。
J Infect Dis. 2006 Aug 1;194(3):302-6. doi: 10.1086/505079. Epub 2006 Jun 22.
7
Comparative in vivo expression of amastigote up regulated Leishmania genes in three different forms of Leishmaniasis.利什曼原虫无鞭毛体上调基因在三种不同形式利什曼病中的体内表达比较
Parasitol Int. 2010 Jun;59(2):262-4. doi: 10.1016/j.parint.2009.11.003. Epub 2009 Dec 4.
8
A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy.在接受高效抗逆转录病毒治疗的埃塞俄比亚艾滋病毒阳性患者中,出现了一种具有 ITS1 序列多态性的利什曼原虫临床分离株,这是引起副皮肤利什曼病的原因。
Br J Dermatol. 2010 Oct;163(4):870-4. doi: 10.1111/j.1365-2133.2010.09768.x.
9
Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients.对来自印度内脏利什曼病和皮肤利什曼原虫病患者的利什曼原虫菌株进行全基因组比较。
Acta Trop. 2021 Nov;223:106086. doi: 10.1016/j.actatropica.2021.106086. Epub 2021 Aug 10.
10
Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.利用重组蛋白 K39 诊断尼泊尔黑热病后皮肤利什曼病
Southeast Asian J Trop Med Public Health. 2007 Jul;38(4):619-25.

引用本文的文献

1
Immune response to viscerotropic : a comprehensive review.内脏亲嗜性的免疫应答:全面综述。
Front Immunol. 2024 Sep 18;15:1402539. doi: 10.3389/fimmu.2024.1402539. eCollection 2024.
2
Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination.印度次大陆的无黑热病皮肤利什曼病:消除的挑战与策略。
Front Immunol. 2023 Aug 11;14:1236952. doi: 10.3389/fimmu.2023.1236952. eCollection 2023.
3
Precision Medicine in Control of Visceral Leishmaniasis Caused by .精准医学控制. 引起的内脏利什曼病
Front Cell Infect Microbiol. 2021 Nov 9;11:707619. doi: 10.3389/fcimb.2021.707619. eCollection 2021.
4
Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL).皮肤利什曼病和内脏利什曼病后皮肤利什曼病(PKDL)的免疫发病机制。
Front Cell Infect Microbiol. 2021 Jun 8;11:685296. doi: 10.3389/fcimb.2021.685296. eCollection 2021.
5
Post kala-azar dermal leishmaniasis: A threat to elimination program.无鞭毛体利什曼原虫病皮肤后:消除规划的威胁。
PLoS Negl Trop Dis. 2020 Jul 2;14(7):e0008221. doi: 10.1371/journal.pntd.0008221. eCollection 2020 Jul.
6
Application of kDNA Minicircle PCR-RFLP to Characterize Clinical Isolates Obtained from Post-Kala-Azar Dermal Leishmaniasis in Eastern Nepal.应用kDNA微环PCR-RFLP技术对尼泊尔东部黑热病后皮肤利什曼病临床分离株进行特征分析
Can J Infect Dis Med Microbiol. 2019 Jul 30;2019:9392414. doi: 10.1155/2019/9392414. eCollection 2019.
7
Analysis of genetic polymorphisms and tropism in East African Leishmania donovani by Amplified Fragment Length Polymorphism and kDNA minicircle sequencing.应用扩增片段长度多态性和 kDNA 微环序列分析东非利什曼原虫的遗传多态性和嗜性。
Infect Genet Evol. 2018 Nov;65:80-90. doi: 10.1016/j.meegid.2018.07.016. Epub 2018 Jul 19.
8
The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis.转移性利什曼病的免疫学、环境学和系统发生学发病因素。
Trends Parasitol. 2014 Aug;30(8):412-22. doi: 10.1016/j.pt.2014.05.006. Epub 2014 Jun 20.
9
Post kala-azar dermal leishmaniasis: an unresolved mystery.内脏利什曼病后皮肤利什曼病:一个悬而未决的谜。
Trends Parasitol. 2014 Feb;30(2):65-74. doi: 10.1016/j.pt.2013.12.004. Epub 2014 Jan 2.
10
Visceral and post-Kala-Azar dermal leishmaniasis isolates show significant difference in their in vitro drug susceptibility pattern.内脏利什曼病和卡拉·阿扎尔后皮肤利什曼病分离株的体外药物敏感性模式存在显著差异。
Parasitol Res. 2013 Mar;112(3):1001-9. doi: 10.1007/s00436-012-3222-1. Epub 2012 Dec 18.